11-2976031-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005969.4(NAP1L4):āc.166A>Gā(p.Ile56Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000807 in 1,611,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 31)
Exomes š: 0.0000075 ( 0 hom. )
Consequence
NAP1L4
NM_005969.4 missense
NM_005969.4 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 7.05
Genes affected
NAP1L4 (HGNC:7640): (nucleosome assembly protein 1 like 4) This gene encodes a member of the nucleosome assembly protein (NAP) family which can interact with both core and linker histones. It can shuttle between the cytoplasm and nucleus, suggesting a role as a histone chaperone. This gene is one of several located near the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.1913498).
BS2
High AC in GnomAdExome4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAP1L4 | NM_005969.4 | c.166A>G | p.Ile56Val | missense_variant | 4/16 | ENST00000380542.9 | NP_005960.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAP1L4 | ENST00000380542.9 | c.166A>G | p.Ile56Val | missense_variant | 4/16 | 1 | NM_005969.4 | ENSP00000369915 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152200
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247328Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134174
GnomAD3 exomes
AF:
AC:
4
AN:
247328
Hom.:
AF XY:
AC XY:
4
AN XY:
134174
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459664Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726138
GnomAD4 exome
AF:
AC:
11
AN:
1459664
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
726138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74346
GnomAD4 genome
AF:
AC:
2
AN:
152200
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.166A>G (p.I56V) alteration is located in exon 4 (coding exon 3) of the NAP1L4 gene. This alteration results from a A to G substitution at nucleotide position 166, causing the isoleucine (I) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;T;T;T;T;T;T;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;.;T;.;.;.;.;.;.;.;.;.;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T;T;T;T;T;T;T;T;T;D;D
Sift4G
Benign
T;T;T;T;.;T;T;.;.;.;.;T;.;.
Polyphen
0.052
.;B;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);.;Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);Gain of catalytic residue at I56 (P = 0.0856);
MVP
MPC
0.22
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at